These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 26514749)
1. Resistant and Refractory Hypertension: Antihypertensive Treatment Resistance vs Treatment Failure. Siddiqui M; Dudenbostel T; Calhoun DA Can J Cardiol; 2016 May; 32(5):603-6. PubMed ID: 26514749 [TBL] [Abstract][Full Text] [Related]
2. Refractory versus resistant hypertension. Siddiqui M; Calhoun DA Curr Opin Nephrol Hypertens; 2017 Jan; 26(1):14-19. PubMed ID: 27798457 [TBL] [Abstract][Full Text] [Related]
3. Refractory Hypertension: Evidence of Heightened Sympathetic Activity as a Cause of Antihypertensive Treatment Failure. Dudenbostel T; Acelajado MC; Pisoni R; Li P; Oparil S; Calhoun DA Hypertension; 2015 Jul; 66(1):126-33. PubMed ID: 25987662 [TBL] [Abstract][Full Text] [Related]
4. Resistant hypertension: an overview of evaluation and treatment. Sarafidis PA; Bakris GL J Am Coll Cardiol; 2008 Nov; 52(22):1749-57. PubMed ID: 19022154 [TBL] [Abstract][Full Text] [Related]
5. Resistant and refractory hypertension: two sides of the same disease? Muxfeldt ES; Chedier B; Rodrigues CIS J Bras Nefrol; 2019; 41(2):266-274. PubMed ID: 30525180 [TBL] [Abstract][Full Text] [Related]
6. Treatment of Resistant and Refractory Hypertension. Acelajado MC; Hughes ZH; Oparil S; Calhoun DA Circ Res; 2019 Mar; 124(7):1061-1070. PubMed ID: 30920924 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of resistant hypertension in the United States, 2003-2008. Persell SD Hypertension; 2011 Jun; 57(6):1076-80. PubMed ID: 21502568 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease. de Beus E; Bots ML; van Zuilen AD; Wetzels JF; Blankestijn PJ; Hypertension; 2015 Nov; 66(5):998-1005. PubMed ID: 26351024 [TBL] [Abstract][Full Text] [Related]
9. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M; Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745 [TBL] [Abstract][Full Text] [Related]
11. Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure. Dudenbostel T; Siddiqui M; Oparil S; Calhoun DA Hypertension; 2016 Jun; 67(6):1085-92. PubMed ID: 27091893 [No Abstract] [Full Text] [Related]
12. Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort. Calhoun DA; Booth JN; Oparil S; Irvin MR; Shimbo D; Lackland DT; Howard G; Safford MM; Muntner P Hypertension; 2014 Mar; 63(3):451-8. PubMed ID: 24324035 [TBL] [Abstract][Full Text] [Related]
13. Refractory and Resistant Hypertension: Antihypertensive Treatment Failure versus Treatment Resistance. Calhoun DA Korean Circ J; 2016 Sep; 46(5):593-600. PubMed ID: 27721847 [TBL] [Abstract][Full Text] [Related]
14. Controversies in Hypertension V: Resistant and Refractory Hypertension. Filippone EJ; Naccarelli GV; Foy AJ Am J Med; 2024 Jan; 137(1):12-22. PubMed ID: 37832756 [TBL] [Abstract][Full Text] [Related]
15. [Therapy Resistant and Refractory Hypertension]. Düsing R Dtsch Med Wochenschr; 2020 Jan; 145(2):87-91. PubMed ID: 31958855 [TBL] [Abstract][Full Text] [Related]
16. Refractory Hypertension Is not Attributable to Intravascular Fluid Retention as Determined by Intracardiac Volumes. Velasco A; Siddiqui M; Kreps E; Kolakalapudi P; Dudenbostel T; Arora G; Judd EK; Prabhu SD; Lloyd SG; Oparil S; Calhoun DA Hypertension; 2018 Aug; 72(2):343-349. PubMed ID: 29866740 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of refractory hypertension in the United States from 1999 to 2014. Buhnerkempe MG; Botchway A; Prakash V; Al-Akchar M; Nolasco Morales CE; Calhoun DA; Flack JM J Hypertens; 2019 Sep; 37(9):1797-1804. PubMed ID: 31058798 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network. Egan BM; Zhao Y; Li J; Brzezinski WA; Todoran TM; Brook RD; Calhoun DA Hypertension; 2013 Oct; 62(4):691-7. PubMed ID: 23918752 [TBL] [Abstract][Full Text] [Related]